Core Insights - Fortrea Holdings Inc. reported quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share, and down from $0.23 per share a year ago, representing an earnings surprise of -25.00% [1] - The company posted revenues of $701.3 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 9.21% and up from $674.9 million year-over-year [2] - Fortrea Holdings Inc. shares have declined approximately 48% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.14 on revenues of $636.86 million, and for the current fiscal year, it is $0.54 on revenues of $2.67 billion [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Fortrea Holdings Inc. belongs, is currently in the top 40% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Fortrea's stock performance [5]
Fortrea Holdings Inc. (FTRE) Q3 Earnings Lag Estimates